ThinkSabio

$NTRA

$392.90▲ +0.6% YTD

12 SEC 13D/G filings tracked · Last updated Oct 9, 2026

Filing History
News
NTRA ▲ +0.6% - Natera, Inc.
CP $392.90▲ +0.6%Oct 9, 2026 · ThinkSabio Blog

$NTRA - FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay…

News
NTRA ▲ +0.6% - Natera, Inc.
CP $392.90▲ +0.6%Oct 9, 2026 · ThinkSabio Blog

$NTRA FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay…

News
NTRA ▼ -0.9% - Natera, Inc.
CP $397.00▲ -0.9%Oct 7, 2026 · ThinkSabio Blog

$NTRA - Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma…

News
NTRA ▲ +1.0% - Natera, Inc.
CP $429.97▲ +1.0%Oct 6, 2026 · ThinkSabio Blog

$NTRA - New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists…

News
NTRA ▲ +1.0% - Natera, Inc.
CP $429.97▲ +1.0%Oct 6, 2026 · ThinkSabio Blog

$NTRA New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists…

News
NTRA ▼ -0.3% - Natera, Inc.
CP $409.00▲ -0.3%Oct 5, 2026 · ThinkSabio Blog

$NTRA - Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Es…

News
NTRA ▼ -0.3% - Natera, Inc.
CP $409.00▲ -0.3%Oct 5, 2026 · ThinkSabio Blog

$NTRA Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estr…

News
NTRA ▼ -0.2% - Natera, Inc.
CP $370.05▲ -0.2%Sep 22, 2026 · ThinkSabio Blog

$NTRA - Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer…

News
NTRA ▼ -0.2% - Natera, Inc.
CP $370.05▲ -0.2%Sep 22, 2026 · ThinkSabio Blog

$NTRA Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer…

News
NTRA ▲ +0.4% - Natera, Inc.
CP $323.30▲ +0.4%Sep 1, 2026 · ThinkSabio Blog

$NTRA - New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma…

News
NTRA ▼ -2.2% - Natera, Inc.
CP $331.21▲ -2.2%Aug 28, 2026 · ThinkSabio Blog

$NTRA - Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer…

SEC 13D/G
NTRA - Natera, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$309.76▲ 35.40%Aug 14, 2026 · ThinkSabio Blog

$NTRA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NTRA Natera, Inc. : $309.76 Sector: Healthcare | YTD: 🔼+ 35.40%…